Radiotherapy Market Future Insights, Share Value, COVID-19 Impact and Emerging Trends By 2027
Radiotherapy Market Highlights
Radiotherapy
is
used for the treatment of various types of cancer. The therapy uses high power
X-rays to destroy cancerous cells. According to the National Cancer Institute,
about 50% of cancer patients receive some type of radiation therapy during
their treatment. The radiotherapy treatment are less painful than the
chemotherapy and surgeries. The damaged cells are broken down by the natural
process of body.
The
cancerous cells get destroyed totally and does not show its presence in future.
The time required is much less in contrast to the chemotherapy. The side
effects of the radiotherapy is also nominal as compared to the chemotherapy.
Around 4 out of every 10 people are treated for cancer undergo radiotherapy.
Normally together with other types of treatment including chemotherapy and
surgery. The market for the radiotherapy is increasing as the treatment is
quick and easy. The treatment is more effective than chemotherapy and surgery.
Though treatment has some side effects but the therapy is widely preferred by
doctors.
The
Global Radiotherapy Market will grow very rapidly at a rate of 7% CAGR during
the forecasted period 2017-2023.
Request
Free Sample Copy at:
https://www.marketresearchfuture.com/sample_request/1526
GE
Healthcare (UK), Siemens (Germany), Cardinal Health (U.S.), Nordion (CA), View
ray (U.S.), Fuji Holdings (Japan), Philips Healthcare (U.S.), Shimadzu
Corporation (Japan), Hologic (U.S.), Varian Medical Systems, Inc. (U.S.),
Elekta AB (Sweden), Accuray Incorporated (U.S.), Ion Beam Applications (IBA)
(Belgium), Nordion, Inc. (Canada), C. R. Bard, Inc. (U.S.), Isoray Medical, Inc.
(U.S.), RaySearch Laboratories (Sweden), Mevion Medical Systems, Inc.
(U.S.), Mitsubishi Electric Corporation
(Japan), CIVCO Medical Solutions (U.S.),
Brainlab AG (Germany), PRECISIS AG (Germany), Technicas Radiofiscas S.L (Spain), Hitachi
Ltd. (Japan), Sumitomo Heavy Industries Ltd. (Japan), ProNova Solutions LLC (U.S.), ProTom
International (U.S.), and others are
some of the prominent players at the forefront of competition in the global
radiotherapy market and are profiled in MRFR Analysis.
Industry Updates
Jan,
2018 Varian Medical Systems signed an agreement to acquire Sirtex Medical
Limited. This acquisition expands Varian's addressable market into
interventional oncology to emerge as a global leader in radio embolization.
October,
2017 Varian has launched its radiotherapy device ProBeam Compact single-room
proton therapy system.
July,
2017 View Ray has recently announced the launch of MRI-guided radiation therapy
solution, MRIdian Linac.
Global Radiotherapy Market – Regional:
Geographically,
the regional market is segmented into America, Europe, Asia Pacific, and the
Middle East & Africa.
America
holds the larger market in the radiotherapy the market increasing due to the
increasing advancement in the technology. The US is the largest market for the
radiotherapy due to the technological advancement. The adoption of new
technology is more in this region as the research and development is also more
and developing day by day. There are many companies who have already captured
the market and developed new technologies for the imaging. The number of cancer
patients are more in this region.
Europe
is the second largest market owing to the advanced technologies due to
increasing R&D. The European region is having its own set of regulations
for the medical regulations. The expenditures are also more by the government
bodies for the healthcare and adoption for the new and sophisticated
technologies.
Asia
pacific region is growing at a rapid pace owing to the increasing number of
patients in the region. The increasing consumptions of tobacco is seen in this
region. The growth is increasing as the economies are increasing governments in
this regions are showing more interest in improving the healthcare sectors. The
R&D in this region is also increasing with the big players operating in
this sector. The number of cancer patients in this region are more. The number
are maximum for the oral and lung cancer. The cases of thyroid are also more in
this region.
Middle East and Africa is slow
growing segment because of the lack of awareness of the chronic diseases and
the treatment facilities are also limited in this region. The regions have slow
growth due to the factors like unskilled labors are more, illiteracy is more,
and economic development is slow. The lack of awareness among the people is
very less. The technological advancement is very less. The distribution network
for the companies is very less. The poverty in this region is very high.
Treatment are not reached to the needy. The cases of cancer is also increasing
in this region but the diagnosis is also less in this region. The treatment for
cancer is far behind as compared to developed and developing region.
Browse Detailed TOC with COVID-19 Impact Analysis at:
https://www.marketresearchfuture.com/reports/radiotherapy-market-1526
About Market Research Future:
At Market Research Future
(MRFR), we enable our customers to unravel the complexity of various industries
through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR),
& Consulting Services. MRFR team have supreme objective to provide the
optimum quality market research and intelligence services to our clients.
Contact:
Akash Anand
Market Research Future
+1 646 845 9312
Email:
sales@marketresearchfuture.com
Comments
Post a Comment